General hospital psychiatry最新文献

{"title":"Sex-specific associations between depressive symptoms and cardiovascular risk among middle-aged and older adults without standard modifiable risk factors: Evaluating the ‘SMuRF-less but depressed’","authors":"Lu Zhai ,&nbsp;Jue-Ling Wei ,&nbsp;Rong-Rui Huo ,&nbsp;Xue-Mei You","doi":"10.1016/j.genhosppsych.2026.01.005","DOIUrl":"10.1016/j.genhosppsych.2026.01.005","url":null,"abstract":"<div><h3>Background</h3><div>The emergence of the ‘SMuRF-less’ (absence of Standard Modifiable Risk Factors) phenotype challenges traditional cardiovascular disease (CVD) prediction models. While depression is an established CVD risk factor, its pathogenic role in the absence of hypertension, diabetes, hypercholesterolemia, and smoking remains unclear, especially regarding potential sex differences.</div></div><div><h3>Methods</h3><div>This prospective analysis included 2484 middle-aged and older adults (≥45 years) free of baseline CVD and all SMuRFs (hypertension, diabetes, hypercholesterolemia, smoking) from the China Health and Retirement Longitudinal Study. Cox proportional hazard models were used to calculate the hazard ratio (HR) and 95% confidence interval (95% CI) for the association between depressive symptoms and CVD events after adjusting for potential confounders. Dose-response associations were examined using restricted cubic splines, and all analyses were stratified by sex.</div></div><div><h3>Results</h3><div>Over a median follow-up of 10.3 years, 523 CVD events occurred. Elevated depressive symptoms were associated with increased risks of CVD (adjusted HR = 1.47, 95% CI: 1.22–1.77), stroke (HR = 1.61, 95% CI: 1.13–2.28), and heart disease (HR = 1.42, 95% CI: 1.16–1.74) in the overall population. However, stratified analysis revealed this association was entirely driven by women, with significant risks for CVD (HR = 1.50, 95% CI: 1.22–1.86) and stroke (HR = 2.08, 95% CI: 1.35–3.21). No significant association was observed in men. A linear negative association was evident in women but not in men.</div></div><div><h3>Conclusions</h3><div>In this SMuRF-less cohort, depressive symptoms independently predicted incident CVD, with the association being particularly strong in women. Our findings identify a “SMuRF-less but depressed” women phenotype that warrants targeted attention in primary prevention.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 43-49"},"PeriodicalIF":3.7,"publicationDate":"2026-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145974314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"General Hospital Psychiatry: Serving the cause of reuniting the brain, mind and body","authors":"Dimitry S. Davydow","doi":"10.1016/j.genhosppsych.2026.01.004","DOIUrl":"10.1016/j.genhosppsych.2026.01.004","url":null,"abstract":"","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 41-42"},"PeriodicalIF":3.7,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145923357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating impact of population health outreach and an interdepartmental approach to perinatal depression","authors":"Lara S. Lemon ,&nbsp;Jennifer Chaney ,&nbsp;Melissa Young ,&nbsp;William Garrard ,&nbsp;Beth Quinn ,&nbsp;Kelly O'Toole ,&nbsp;Priya Gopalan ,&nbsp;Hyagriv N. Simhan","doi":"10.1016/j.genhosppsych.2026.01.003","DOIUrl":"10.1016/j.genhosppsych.2026.01.003","url":null,"abstract":"<div><h3>Objective</h3><div>Evaluate the impact of connecting obstetrics with psychiatry in addressing prenatal depression. We compared patient engagement with behavioral health, prescriptions and follow-up over time after implementation of a population health central team outreach to depressed pregnant persons in 2019. Behavioral health joined the EHR facilitating collaboration in 2020.</div></div><div><h3>Methods</h3><div>In a cohort of deliveries across 8 hospitals from 1/1/2021–12/31/2024, we studied patients who screened positive for depression prenatally.</div></div><div><h3>Outcomes</h3><div>1. Documentation of behavioral health visit while pregnant or within 1 year postpartum, 2. Antidepressant prescription while pregnant or within 1 year postpartum, and 3. Compliance with Pennsylvania's Medicaid obstetric reimbursement bundle quality metric for depression follow-up within 30 days of positive screen. Secondary analyses explored collaboration by limiting to targeted behavioral health departments and explored impact of telemedicine.</div></div><div><h3>Results</h3><div>Of 54,483 deliveries, 48,238 (89 %) were administered the PHQ-2/9, 5139 screened positive and 3732 had 1-year postpartum follow-up. As collaboration efforts increased and the population health team expanded, we observed a linear increase in engagement with behavioral health and adherence with depression follow-up. Depressed pregnant persons delivering in 2023 were 50 % more likely to have a behavioral health visit (adjOR 1.54; 95 % CI: 1.25, 1.91) and 40 % more likely to have follow-up (adjOR 1.41, 95 % CI: 1.21, 1.65) compared with persons delivering in 2021. These trends were stronger when limiting to collaborative behavioral health departments.</div></div><div><h3>Conclusion</h3><div>A cross-disciplinary care model facilitated by centralized population health team is an impactful approach to connect depressed pregnant persons with appropriate care.</div><div>2890/4000; /4 tables or figures.</div></div><div><h3>Precis</h3><div>A cross-discipline approach facilitated by a population health team increased behavioral health engagement for patients with perinatal depression.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 24-29"},"PeriodicalIF":3.7,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145923288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Challenges of enrolling participants with alcohol and opioid use disorders in the emergency department for clinical trials of ketamine: The experience from two randomized controlled trials","authors":"P.R. Chai ,&nbsp;E. Lee ,&nbsp;M.A. Hasdianda ,&nbsp;M. Bianchi ,&nbsp;D. Campbell ,&nbsp;C. Goldfine ,&nbsp;J. Suzuki","doi":"10.1016/j.genhosppsych.2025.12.019","DOIUrl":"10.1016/j.genhosppsych.2025.12.019","url":null,"abstract":"<div><h3>Purpose of research</h3><div>Application of psychedelics including ketamine may be important adjuncts in the treatment of alcohol and opioid use disorders. Most patients with alcohol or opioid use disorder (AUD/OUD) may present to the emergency department (ED) seeking care both for substance use and associated complaints. Understanding safety and preliminary efficacy of ketamine and other psychedelics to improve the care and potentially facilitate linkage to long term care for AUD/OUD in the ED is of high importance. Here, we describe our experience conducting rigorous double blind placebo controlled trials to evaluate safety of ketamine in the ED for AUD/OUD and the challenges in conducting this research among this important population.</div></div><div><h3>Principal results</h3><div>We conducted two studies to evaluate the safety of a single dose ketamine infusion for individuals seeking detox with AUD and those seeking psychiatric care who had OUD. Studies were conducted at an urban community and academic ED with variable pharmacy capabilities. Over the study period study 1 (AUD) screened <em>N</em> = 180 individuals for the study of which <em>N</em> = 3 were preliminarily eligible. None were able to pass full eligibility criteria resulting in no enrollments. Study 2 (OUD) screened <em>N</em> = 234 ED visits were screen of which <em>N</em> = 8 were eligible and <em>N</em> = 4 consented. All four participants were successfully randomized and treated with ketamine or placebo. We were unable to conduct follow up in any of the participants.</div></div><div><h3>Major conclusions</h3><div>Enrollment of ED patients with AUD/OUD for ketamine trials in the ED is difficult and fraught with multiple challenges. Even with enrollment in the ED, follow up can be a significant challenge. This reinforces the need to consider innovative strategies to conduct ketamine and other psychedelic related trials among ED patients with AUD/OUD.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"98 ","pages":"Pages 159-164"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145862004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Internet-based problem solving therapy improves depressive and dialysis related physical symptoms in hemodialysis patients under 65 years of age: A post-hoc secondary subgroup analysis of a cluster randomized controlled trial","authors":"Debbie Zittema ,&nbsp;Robbert W. Schouten ,&nbsp;Els Nadort ,&nbsp;Rosa E. Boeschoten ,&nbsp;Yves Smets ,&nbsp;Prataap Chandie Shaw ,&nbsp;Louis Jean Vleming ,&nbsp;Marijke J.E. Dekker ,&nbsp;Michiel Westerman ,&nbsp;Ellen K. Hoogeveen ,&nbsp;Willem J.W. Bos ,&nbsp;Marcel Schouten ,&nbsp;Karima Farhat ,&nbsp;Patricia van Oppen ,&nbsp;Friedo W. Dekker ,&nbsp;Carl E.H. Siegert ,&nbsp;Birit F.P. Broekman","doi":"10.1016/j.genhosppsych.2025.12.022","DOIUrl":"10.1016/j.genhosppsych.2025.12.022","url":null,"abstract":"<div><h3>Background and hypothesis</h3><div>Patients on hemodialysis therapy often experience a high burden of mental and physical health symptoms. We developed a guided internet-based self-help problem-solving therapy (IPST) targeted on practical daily life issues. While we did not find an effect for all patients, we hypothesized that an internet intervention might be effective in younger patients below 65 years of age. In this post-hoc secondary subgroup analysis we divided our study population based on age to study the effect of our intervention on depressive- and dialysis-related symptoms.</div></div><div><h3>Methods</h3><div>Chronic hemodialysis patients with a depression score on the Beck Depression Inventory (BDI-II) of ≥10, were randomized into a five modules guided IPST or a care-as-usual control group. The study population was stratified by age (&lt; 65 and ≥ 65 years). The primary outcome was depressive symptoms (BDI-II). Secondary outcomes were anxiety (BAI), health-related quality of life (HRQoL) and dialysis related symptoms (DSI). Analyses were performed using linear mixed models.</div></div><div><h3>Results</h3><div>122 out of 190 randomized patients completed post-intervention measurements. In 25 younger patients (age &lt; 65), a significant effect was found in reduction of BDI-II (−30 %, <em>p</em> = 0.04) and DSI (presence of symptoms: −27 %, <em>p</em> = 0.001; level of distress: −25 %, <em>p</em> = 0.03). No effect was seen on BAI or HRQoL. In the older population (<em>n</em> = 29), no effect of the intervention was found on any outcomes.</div></div><div><h3>Conclusion</h3><div>An easy to implement guided IPST showed a clinically relevant decrease in depressive symptoms and dialysis related physical symptoms in hemodialysis patients aged below 65 years although results should be interpreted cautiously given the post-hoc design.</div></div><div><h3>Trial registration</h3><div>Dutch Trial Register: Trial NL6648 (NTR6834) (prospectively registered 13th November 2017).</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"98 ","pages":"Pages 165-171"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145880469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing DSM-5 criteria of somatic symptom disorder in medically hospitalized inpatients: A cross-sectional analysis","authors":"Sebastian Dietsche ,&nbsp;Franziska Weeren ,&nbsp;Gunther Meinlschmidt ,&nbsp;Anne Toussaint ,&nbsp;Iris Baenteli ,&nbsp;Sanaa Bahmane ,&nbsp;Alex Frick ,&nbsp;Christina Karpf ,&nbsp;Anja Studer ,&nbsp;Kaspar Wyss ,&nbsp;Matthias Schwenkglenks ,&nbsp;Günther Fink ,&nbsp;Sibil Tschudin ,&nbsp;Sarah Trost ,&nbsp;Marco Bachmann ,&nbsp;Andreas Dörner ,&nbsp;David Buechel ,&nbsp;Lukas Ebner ,&nbsp;Rainer Schaefert ,&nbsp;the SomPsyNet Consortium","doi":"10.1016/j.genhosppsych.2025.12.023","DOIUrl":"10.1016/j.genhosppsych.2025.12.023","url":null,"abstract":"<div><h3>Introduction</h3><div>In the revised DSM-5, Somatic Symptom Disorder (SSD) no longer requires medically unexplained symptoms and instead focuses on psychobehavioral positive criteria, applicable regardless of the underlying cause. Evidence on the frequency and characteristics of SSD among medically hospitalized inpatients remains scarce. We therefore investigated SSD frequency and age- and gender-associated characteristics in this population.</div></div><div><h3>Methods</h3><div>This cross-sectional analysis used baseline data from SomPsyNet, an intervention targeting SOMatic hospital inpatients to prevent PSYchosocial distress through a care NETwork. SSD was assessed using the Somatic Symptom Scale-8 (SSS-8) and the Somatic Symptom Disorder-B Criteria Scale (SSD-12), applying DSM-5-aligned and established cut-offs. Criteria were operationalized as A) somatic symptom burden (SSS-8 sum score ≥ 9 or per item≥3), B) symptom-related distress (SSD-12 ≥ 23), and C) proxies for symptom persistence. Associations with age were examined using robust regression.</div></div><div><h3>Results</h3><div>Among 3109 inpatients enrolled between June 2020 and December 2022, 20.6 % (SSS-8 sum score ≥ 9) to 21.9 % (SSS-8 per item≥3) met all three SSD criteria. Among the 25.5 % of patients positive for Criterion B (SSD-12 ≥ 23), Criteria A and C were frequently also met. No female predominance in symptom-related distress was observed. Younger patients reported higher somatic symptom burden and symptom-related distress (SSS-8: <em>B</em> = -0.04, <em>t</em> = −7.51; SSD-12: <em>B</em> = -0.05, <em>t</em> = −5.11).</div></div><div><h3>Conclusion</h3><div>Symptoms consistent with DSM-5 SSD criteria were common among medically hospitalized inpatients. These findings underscore the frequency of SSD-related distress in this setting, highlight age- and gender-related differences in symptom presentation, and emphasize the need for further research to clarify its clinical implications.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 6-15"},"PeriodicalIF":3.7,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient-reported outcomes and acceptability of suggestion and hypnosis-based therapy for functional neurological disorder within an NHS service","authors":"Anjana Lukose ,&nbsp;Abhijit Das","doi":"10.1016/j.genhosppsych.2025.12.024","DOIUrl":"10.1016/j.genhosppsych.2025.12.024","url":null,"abstract":"","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 1-3"},"PeriodicalIF":3.7,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessing capacity at an academic medical center: Epidemiology, predictors of outcomes, and the role of surrogate decision makers","authors":"Alyssa M. Nelson ,&nbsp;Sushmitha Divakar ,&nbsp;Daniel J. Daunis ,&nbsp;Jonathan D. Smith ,&nbsp;Timothy Adegoke ,&nbsp;Devin Greene ,&nbsp;Jo Ellen Wilson","doi":"10.1016/j.genhosppsych.2025.12.025","DOIUrl":"10.1016/j.genhosppsych.2025.12.025","url":null,"abstract":"","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 4-5"},"PeriodicalIF":3.7,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associations of cognitive function and depression with future cancer risk in middle-aged and older adults: Findings from a National China Survey","authors":"Zi-Mu Chen ,&nbsp;He-Li Sun ,&nbsp;Yue-Ying Wang ,&nbsp;Yuan Feng ,&nbsp;Qinge Zhang ,&nbsp;Zhaohui Su ,&nbsp;Teris Cheung ,&nbsp;Gabor S. Ungvari ,&nbsp;Hua-Qing Xing ,&nbsp;Qian-Hua Huang ,&nbsp;Todd Jackson ,&nbsp;Gang Wang ,&nbsp;Yu-Tao Xiang","doi":"10.1016/j.genhosppsych.2025.12.020","DOIUrl":"10.1016/j.genhosppsych.2025.12.020","url":null,"abstract":"<div><h3>Background</h3><div>While links between depression and cancer risk are well documented, specific depressive symptoms involved remain unclear, as does the presence of associations between cognitive function and cancer risk. To address these gaps, we assessed associations of cognitive function levels and depressive symptoms with cancer occurrence among middle-aged and older Chinese adults.</div></div><div><h3>Methods</h3><div>This prospective cohort study utilized 2011 to 2020 data from the CHARLS, a population-based nationwide survey from China. Adults aged 45 years or older with cognitive function and depressive symptom data and no baseline cancer diagnosis were included for analysis. Global cognitive function scores were calculated for executive function and episodic memory performance using an adapted version of the Telephone Interview for Cognitive Status. Depressive symptoms were assessed using the CESD-10. Risk of events was reported based on adjusted HRs and 95 % CIs for cancer incidence, using a Cox proportional hazards regression model.</div></div><div><h3>Results</h3><div>Of 16,518 cancer-free adults (mean [SD] age: 56.5 [8.9] years) assessed at baseline, 244 new cancer cases were diagnosed (mean [SD] age: 57.6 [8.9] years) during a median follow-up period of 9 years (IQR, 7–9 years). A lower level of executive function (adjusted HR [95 %CI], 0.69 [0.52–0.92]) and higher somatic retardation levels (adjusted HR [95 %CI], 1.34 [1.00–1.79]) were associated with higher subsequent risk of cancer incidence, after controlling for the impact of demographic characteristics, health-related lifestyle factors and medical conditions.</div></div><div><h3>Conclusion</h3><div>In this longitudinal cohort study, lower initial levels of executive function and higher somatic retardation depressive symptom levels predicted higher subsequent cancer incidence.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 16-23"},"PeriodicalIF":3.7,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145899924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychological support can be distinguished from psychotherapy: Clarifications for future empirical work","authors":"Jonathan R. Schettino ,&nbsp;Katherine Cheung ,&nbsp;Sandeep M. Nayak ,&nbsp;Brandon M. Weiss ,&nbsp;David B. Yaden","doi":"10.1016/j.genhosppsych.2025.12.021","DOIUrl":"10.1016/j.genhosppsych.2025.12.021","url":null,"abstract":"<div><div>Classic psychedelic studies involve interpersonal interactions with participants before, during, and after the acute effects of psychedelics. In the field of psychedelic research, there is currently a debate about whether this interpersonal interaction is most accurately considered “psychological support,” “psychotherapy,” or something else. Proponents of the psychological support label describe the interpersonal interaction in most classic psychedelic studies as aimed at safety, while proponents of the psychotherapy label argue that the interpersonal interaction involves intervening on psychotherapeutic processes that not only support safety, but also contribute to treatment efficacy. However, we believe that the debate has so far been largely unproductive due to a lack of shared definitions or criteria for the relevant interpersonal interactions. Here, we propose definitions and criteria for two viable forms of interpersonal interaction in psychedelic administration: one directed solely towards safety (psychological support) and one directed towards both safety and efficacy (psychotherapy). We then trial our proposed criteria on a sample of 11 published classic psychedelic clinical trials. Our procedure categorized 10 out of 11 studies as being more or less consistent with psychological support or psychotherapy, but achieved clear distinctions in only 4 out of 11 studies. Given these findings, we argue that higher quality data on the interpersonal interaction is needed to clearly distinguish between psychological support and psychotherapy. We conclude by suggesting ways that our criteria can be used in the future to empirically test the relative safety and efficacy of psychological support vs. psychotherapy in psychedelic medicine.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"99 ","pages":"Pages 30-40"},"PeriodicalIF":3.7,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145923289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}